Chris indicates he will complete the animal antiviral studies as well as blood pressure studies. In my opinion, these studies will pave the way for major pharmaceutical developments. If successful, I see Lexaria becoming a biotech pharmaceutical company perhaps as soon as the first half of next year. I also suspect big pharma may come knocking on Lexaria's door once these studies prove the concept of faster, smaller, and more bio-available medication delivery. This is big news for those who can see the whole picture, understand it.
https://www.youtube.com/watch?v=mHthJx3ObGU&a...e=youtu.be